|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | |
| A61K 31/496 | |||
| A61K 31/40 | |||
| A61K 31/519 | |||
| A61K 31/551 | |||
| A61K 31/5513 | |||
| A61K 31/554 | |||
| A61P 25/18 |
| (11) | Number of the document | 3346999 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16766051.3 |
| Date of filing the European patent application | 2016-09-08 | |
| (97) | Date of publication of the European application | 2018-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2016/052778 |
| Date | 2016-09-08 |
| (87) | Number | WO 2017/042567 |
| Date | 2017-03-16 |
| (30) | Number | Date | Country code |
| 201515986 | 2015-09-09 | GB |
| (72) |
ROBSON, Philip, GB
GUY, Geoffrey, GB
WRIGHT, Stephen, GB
CHEETHAM, Emma, GB
SCHILLER, Dominic, GB
|
| (73) |
GW Research Limited,
Sovereign House, Vision Park Histon, Cambridge, CB24 9BZ,
GB
|
| (54) | USE OF CANNABIDIOL IN THE TREATMENT OF MENTAL DISORDERS |
| USE OF CANNABIDIOL IN THE TREATMENT OF MENTAL DISORDERS |